BF Biosciences gains DRAP's approval for brownfield expansion

MG News | September 09, 2024 at 11:49 AM GMT+05:00

0:00

September 09, 2024 (MLN): BF Biosciences Limited, a subsidiary of Ferozsons Laboratories Limited (PSX: FEROZ), has secured approval from the Drug Regulatory Authority of Pakistan (DRAP) for its brownfield expansion (Line II).

This expansion includes a pre-filled syringes line, a liquid and lyophilized line, and a product development section.

The commercial production from the pre-filled syringes line has commenced, whereas the liquid & lyophilized line is under internal validation and will start commercial production in the second quarter of FY 2024-25.

Additionally, BF Biosciences Limited has launched Sematide (Semaglutide) in a pre-filled syringe.

Sematide is the first Glucagon-Like Peptide 1 (GLP1) receptor agonist approved for local manufacture in Pakistan, offering a convenient solution for diabetes management.

The pre-filled syringe eliminates dosing errors and is easy to use by the patients.

Sematide is being manufactured at the new state-of-the-art European prefilled syringes line of BF Biosciences Limited.

Copyright Mettis Link News

Related News

Name	Price/Vol	%Chg/NChg
KSE100	166,283.55 167.56M	0.08% 138.20
ALLSHR	100,743.06 606.86M	0.18% 177.75
KSE30	50,481.85 68.41M	-0.03% -14.33
KMI30	238,092.04 74.86M	0.08% 183.16
KMIALLSHR	65,617.46 221.67M	0.08% 53.04
BKTi	45,081.48 14.67M	-0.08% -34.71
OGTi	33,080.66 7.44M	0.16% 54.22

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	92,830.00	94,440.00 92,030.00	-435.00 -0.47%
BRENT CRUDE	63.48	63.62 62.53	0.81 1.29%
RICHARDS BAY COAL MONTHLY	91.00	0.00 0.00	-0.70 -0.76%
ROTTERDAM COAL MONTHLY	97.00	97.90 97.00	-1.50 -1.52%
USD RBD PALM OLEIN	1,016.00	1,016.00 1,016.00	0.00 0.00%
CRUDE OIL - WTI	59.88	60.02 58.81	0.93 1.58%
SUGAR #11 WORLD	14.90	15.00 14.78	-0.03 -0.20%